Adagene Inc Adr (ADAG)

Mar 02, 2026

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Short Interest Down 24.5% in February - MarketBeat

Mar 02, 2026

Feb 25, 2026

Adagene Spotlights ADG126+KEYTRUDA Data, Late-Line MSS-CRC Focus in Oppenheimer Conference Talk - MarketBeat

Feb 25, 2026

Feb 23, 2026

Comparing KALA BIO (NASDAQ:KALA) and Adagene (NASDAQ:ADAG) - Defense World

Feb 23, 2026

Feb 17, 2026

Adagene to Participate in Two Upcoming Investor Conferences - The Manila Times

Feb 17, 2026

Feb 17, 2026

Adagene sets Oppenheimer, Leerink fireside chats for Feb. 25, March 9 - Stock Titan

Feb 17, 2026

Feb 16, 2026

Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders - TradingView

Feb 16, 2026

Feb 12, 2026

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Rises By 283.2% - Defense World

Feb 12, 2026

Feb 11, 2026

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Expands By 283.2% - MarketBeat

Feb 11, 2026

Jan 31, 2026

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Drops By 31.1% - MarketBeat

Jan 31, 2026

Jan 29, 2026

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Jan 29, 2026

Jan 29, 2026

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jan 29, 2026

Jan 23, 2026

Adagene Provides Business Update and 2026 Objectives - The Manila Times

Jan 23, 2026

Jan 16, 2026

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Rises By 48.9% - MarketBeat

Jan 16, 2026

Jan 06, 2026

Total debt per share of Adagene, Inc. Sponsored ADR – LS:A2QN45 - TradingView — Track All Markets

Jan 06, 2026

Jan 04, 2026

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 04, 2026

Dec 28, 2025

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Declines By 36.8% - MarketBeat

Dec 28, 2025

Dec 19, 2025

Analysts Set Expectations for Adagene FY2025 Earnings - Defense World

Dec 19, 2025

Dec 18, 2025

Analysts Issue Forecasts for Adagene FY2025 Earnings - MarketBeat

Dec 18, 2025

Dec 18, 2025

FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug - The Globe and Mail

Dec 18, 2025

Dec 16, 2025

Adagene, Palvella up after FDA Fast Track tags (ADAG:NASDAQ) - Seeking Alpha

Dec 16, 2025

Dec 16, 2025

Adagene stock soars after FDA grants Fast Track status for cancer therapy - Investing.com Nigeria

Dec 16, 2025

Dec 16, 2025

Adagene stock soars after FDA grants Fast Track status for cancer therapy By Investing.com - Investing.com South Africa

Dec 16, 2025

Dec 16, 2025

FDA grants fast track status to Adagene’s muzastotug for colorectal cancer - Investing.com

Dec 16, 2025

Dec 16, 2025

FDA grants fast track status to Adagene’s muzastotug for colorectal cancer By Investing.com - Investing.com South Africa

Dec 16, 2025

Dec 16, 2025

Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126) - GlobeNewswire

Dec 16, 2025

Dec 13, 2025

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives $7.67 Consensus Target Price from Analysts - Defense World

Dec 13, 2025

Nov 28, 2025

Adagene (NASDAQ:ADAG) Earns Buy Rating from Analysts at Guggenheim - Defense World

Nov 28, 2025

Nov 27, 2025

Adagene (NASDAQ:ADAG) Now Covered by Guggenheim - MarketBeat

Nov 27, 2025

Nov 24, 2025

Get in on Adagene Inc ADR’s (ADAG) buy-in window today! - Setenews

Nov 24, 2025

Nov 21, 2025

Can Adagene Inc. Depositary Receipt stock double in next 5 years2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com

Nov 21, 2025

Nov 18, 2025

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives $7.00 Average Target Price from Analysts - Defense World

Nov 18, 2025

Nov 17, 2025

Adagene (NASDAQ:ADAG) Upgraded at Lifesci Capital - Defense World

Nov 17, 2025

Nov 13, 2025

Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology - wahanariau.com

Nov 13, 2025

Nov 13, 2025

Adagene and Third Arc Bio Forge Licensing Agreement for Cancer Therapy Development - TipRanks

Nov 13, 2025

Nov 13, 2025

Adagene Inc. Announces Licensing Agreement with Third Arc Bio to Utilize SAFEbody Technology for CD3 T Cell Engagers - Quiver Quantitative

Nov 13, 2025

Nov 13, 2025

Adagene Announces Licensing Agreement with Third Arc Bio - GlobeNewswire

Nov 13, 2025

Nov 12, 2025

Why Adagene Inc. Depositary Receipt stock is in analyst buy zoneTrade Performance Summary & Weekly High Potential Alerts - newser.com

Nov 12, 2025

Nov 08, 2025

Why Adagene Inc. Depositary Receipt stock is a must watch in 2025Weekly Loss Report & Reliable Trade Execution Plans - newser.com

Nov 08, 2025

Nov 06, 2025

What’s the recovery path for long term holders of Adagene Inc. Depositary ReceiptExit Point & High Win Rate Trade Alerts - newser.com

Nov 06, 2025

Nov 06, 2025

Adagene Inc. Depositary Receipt stock daily chart insightsQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com

Nov 06, 2025

Nov 03, 2025

Understanding Adagene Inc. Depositary Receipt’s price movement2025 Market Outlook & Community Supported Trade Ideas - newser.com

Nov 03, 2025

Nov 01, 2025

Adagene doses first patient in Phase 2 trial of muzastotug for MSS CRC - Investing.com India

Nov 01, 2025

Oct 31, 2025

[F-3] Adagene Inc. Foreign Issuer Shelf Registration | ADAG SEC FilingForm F-3 - Stock Titan

Oct 31, 2025